tradingkey.logo
tradingkey.logo
Search

Globus Medical Inc

GMED
Add to Watchlist
79.145USD
-0.085-0.11%
Close 06/22, 16:00ETQuotes delayed by 15 min
10.74BMarket Cap
18.22P/E TTM

Earnings Forecast

Currency: USD Updated: 2026-06-22
Previous score
7.63
Change
0
The current earnings forecast score of Globus Medical Inc is 7.63, ranking 131 out of 203 in the Healthcare Equipment & Supplies industry. The average price target is 92.00, with a high of 114.00 and a low of 76.00.

Analyst Rating

Based on 15 analysts
Buy
Current Rating
107.917
Target Price
+36.21%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

117
Total
6
Median
9
Average
Company name
Ratings
Analysts
Globus Medical Inc
GMED
15
Medtronic PLC
MDT
34
Dexcom Inc
DXCM
32
Stryker Corp
SYK
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
30
1
2
3
...
24

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Forecast
Actual

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

FAQs

What is Globus Medical Inc's expected revenue for the next quarter?

Globus Medical Inc's expected revenue is 782.87M.

What is Globus Medical Inc's price target?

Analysts forecast that Globus Medical Inc's price target is USD 92.00, with the highest forecast at USD 114.00 and the lowest forecast at USD 76.00.

How have Globus Medical IncGMED's recent earnings per share performed?

The market expectation was USD 0.92, while Globus Medical IncGMED's earnings per share (EPS) for the previous quarter was USD 1.05. EPS for the next quarter is expected at USD 1.10.

What is the analyst rating for Globus Medical Inc?

Based on the ratings of Globus Medical Inc's stock from 15 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
KeyAI